Global Graves Disease Treatment market growth is projected to reach  US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Global Graves Disease Treatment Market Trends and Analysis 2025-31

The global Graves Disease Treatment market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. Graves disease isan immune system disorder that results in the overproduction of thyroid hormones (hyperthyroidism). Although a number of disorders may result in hyperthyroidism, Graves disease is a common cause. Thyroid hormones affect many body systems, so signs and symptoms of Graves disease can be wide ranging. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. Infinity Market Research newest research report, the Graves Disease Treatment Industry Forecast looks at past sales and reviews total world Graves Disease Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Graves Disease Treatment sales for 2025 through 2031. With Graves Disease Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Graves Disease Treatment industry. This Insight Report provides a comprehensive analysis of the global Graves Disease Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Graves Disease Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Graves Disease Treatment market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Graves Disease Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Graves Disease Treatment. This report presents a comprehensive overview, market shares, and growth opportunities of Graves Disease Treatment market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Anti-Thyroid Medication &nbsp;&nbsp;&nbsp; Radioactive Iodine Therapy Segmentation by Application: &nbsp;&nbsp;&nbsp; Hospitals Pharmacies &nbsp;&nbsp;&nbsp; Retail Pharmacies This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Abbott &nbsp;&nbsp;&nbsp; Merck & Co &nbsp;&nbsp;&nbsp; Pfizer, Inc &nbsp;&nbsp;&nbsp; AbbVie, Inc &nbsp;&nbsp;&nbsp; Mylan N.V &nbsp;&nbsp;&nbsp; Allergan, plc &nbsp;&nbsp;&nbsp; Novartis AG &nbsp;&nbsp;&nbsp; Apitope &nbsp;&nbsp;&nbsp; Amgen INC. &nbsp;&nbsp;&nbsp; Sun Pharmaceuticals Industries LTD &nbsp;&nbsp;&nbsp; Immunovant Inc Key Questions Addressed in this Report What is the 10-year outlook for the global Graves Disease Treatment market? What factors are driving Graves Disease Treatment market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Graves Disease Treatment market opportunities vary by end market size? How does Graves Disease Treatment break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Graves Disease Treatment Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Graves Disease Treatment by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Graves Disease Treatment by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Graves Disease Treatment Segment by Type &nbsp;2.2.1 Anti-Thyroid Medication &nbsp;2.2.2 Radioactive Iodine Therapy &nbsp;2.3 Graves Disease Treatment Sales by Type &nbsp;2.3.1 Global Graves Disease Treatment Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Graves Disease Treatment Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Graves Disease Treatment Sale Price by Type (2020-2025) &nbsp;2.4 Graves Disease Treatment Segment by Application &nbsp;2.4.1 Hospitals Pharmacies &nbsp;2.4.2 Retail Pharmacies &nbsp;2.5 Graves Disease Treatment Sales by Application &nbsp;2.5.1 Global Graves Disease Treatment Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Graves Disease Treatment Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Graves Disease Treatment Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Graves Disease Treatment Breakdown Data by Company &nbsp;3.1.1 Global Graves Disease Treatment Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Graves Disease Treatment Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Graves Disease Treatment Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Graves Disease Treatment Revenue by Company (2020-2025) &nbsp;3.2.2 Global Graves Disease Treatment Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Graves Disease Treatment Sale Price by Company &nbsp;3.4 Key Manufacturers Graves Disease Treatment Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Graves Disease Treatment Product Location Distribution &nbsp;3.4.2 Players Graves Disease Treatment Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Graves Disease Treatment by Geographic Region &nbsp;4.1 World Historic Graves Disease Treatment Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Graves Disease Treatment Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Graves Disease Treatment Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Graves Disease Treatment Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Graves Disease Treatment Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Graves Disease Treatment Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Graves Disease Treatment Sales Growth &nbsp;4.4 APAC Graves Disease Treatment Sales Growth &nbsp;4.5 Europe Graves Disease Treatment Sales Growth &nbsp;4.6 Middle East & Africa Graves Disease Treatment Sales Growth 5 Americas &nbsp;5.1 Americas Graves Disease Treatment Sales by Country &nbsp;5.1.1 Americas Graves Disease Treatment Sales by Country (2020-2025) &nbsp;5.1.2 Americas Graves Disease Treatment Revenue by Country (2020-2025) &nbsp;5.2 Americas Graves Disease Treatment Sales by Type (2020-2025) &nbsp;5.3 Americas Graves Disease Treatment Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Graves Disease Treatment Sales by Region &nbsp;6.1.1 APAC Graves Disease Treatment Sales by Region (2020-2025) &nbsp;6.1.2 APAC Graves Disease Treatment Revenue by Region (2020-2025) &nbsp;6.2 APAC Graves Disease Treatment Sales by Type (2020-2025) &nbsp;6.3 APAC Graves Disease Treatment Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Graves Disease Treatment by Country &nbsp;7.1.1 Europe Graves Disease Treatment Sales by Country (2020-2025) &nbsp;7.1.2 Europe Graves Disease Treatment Revenue by Country (2020-2025) &nbsp;7.2 Europe Graves Disease Treatment Sales by Type (2020-2025) &nbsp;7.3 Europe Graves Disease Treatment Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Graves Disease Treatment by Country &nbsp;8.1.1 Middle East & Africa Graves Disease Treatment Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Graves Disease Treatment Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Graves Disease Treatment Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Graves Disease Treatment Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Graves Disease Treatment &nbsp;10.3 Manufacturing Process Analysis of Graves Disease Treatment &nbsp;10.4 Industry Chain Structure of Graves Disease Treatment 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Graves Disease Treatment Distributors &nbsp;11.3 Graves Disease Treatment Customer 12 World Forecast Review for Graves Disease Treatment by Geographic Region &nbsp;12.1 Global Graves Disease Treatment Market Size Forecast by Region &nbsp;12.1.1 Global Graves Disease Treatment Forecast by Region (2026-2031) &nbsp;12.1.2 Global Graves Disease Treatment Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Graves Disease Treatment Forecast by Type (2026-2031) &nbsp;12.7 Global Graves Disease Treatment Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 Abbott &nbsp;13.1.1 Abbott Company Information &nbsp;13.1.2 Abbott Graves Disease Treatment Product Portfolios and Specifications &nbsp;13.1.3 Abbott Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 Abbott Main Business Overview &nbsp;13.1.5 Abbott Latest Developments &nbsp;13.2 Merck & Co &nbsp;13.2.1 Merck & Co Company Information &nbsp;13.2.2 Merck & Co Graves Disease Treatment Product Portfolios and Specifications &nbsp;13.2.3 Merck & Co Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 Merck & Co Main Business Overview &nbsp;13.2.5 Merck & Co Latest Developments &nbsp;13.3 Pfizer, Inc &nbsp;13.3.1 Pfizer, Inc Company Information &nbsp;13.3.2 Pfizer, Inc Graves Disease Treatment Product Portfolios and Specifications &nbsp;13.3.3 Pfizer, Inc Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 Pfizer, Inc Main Business Overview &nbsp;13.3.5 Pfizer, Inc Latest Developments &nbsp;13.4 AbbVie, Inc &nbsp;13.4.1 AbbVie, Inc Company Information &nbsp;13.4.2 AbbVie, Inc Graves Disease Treatment Product Portfolios and Specifications &nbsp;13.4.3 AbbVie, Inc Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 AbbVie, Inc Main Business Overview &nbsp;13.4.5 AbbVie, Inc Latest Developments &nbsp;13.5 Mylan N.V &nbsp;13.5.1 Mylan N.V Company Information &nbsp;13.5.2 Mylan N.V Graves Disease Treatment Product Portfolios and Specifications &nbsp;13.5.3 Mylan N.V Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 Mylan N.V Main Business Overview &nbsp;13.5.5 Mylan N.V Latest Developments &nbsp;13.6 Allergan, plc &nbsp;13.6.1 Allergan, plc Company Information &nbsp;13.6.2 Allergan, plc Graves Disease Treatment Product Portfolios and Specifications &nbsp;13.6.3 Allergan, plc Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 Allergan, plc Main Business Overview &nbsp;13.6.5 Allergan, plc Latest Developments &nbsp;13.7 Novartis AG &nbsp;13.7.1 Novartis AG Company Information &nbsp;13.7.2 Novartis AG Graves Disease Treatment Product Portfolios and Specifications &nbsp;13.7.3 Novartis AG Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 Novartis AG Main Business Overview &nbsp;13.7.5 Novartis AG Latest Developments &nbsp;13.8 Apitope &nbsp;13.8.1 Apitope Company Information &nbsp;13.8.2 Apitope Graves Disease Treatment Product Portfolios and Specifications &nbsp;13.8.3 Apitope Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.8.4 Apitope Main Business Overview &nbsp;13.8.5 Apitope Latest Developments &nbsp;13.9 Amgen INC. &nbsp;13.9.1 Amgen INC. Company Information &nbsp;13.9.2 Amgen INC. Graves Disease Treatment Product Portfolios and Specifications &nbsp;13.9.3 Amgen INC. Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.9.4 Amgen INC. Main Business Overview &nbsp;13.9.5 Amgen INC. Latest Developments &nbsp;13.10 Sun Pharmaceuticals Industries LTD &nbsp;13.10.1 Sun Pharmaceuticals Industries LTD Company Information &nbsp;13.10.2 Sun Pharmaceuticals Industries LTD Graves Disease Treatment Product Portfolios and Specifications &nbsp;13.10.3 Sun Pharmaceuticals Industries LTD Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.10.4 Sun Pharmaceuticals Industries LTD Main Business Overview &nbsp;13.10.5 Sun Pharmaceuticals Industries LTD Latest Developments &nbsp;13.11 Immunovant Inc &nbsp;13.11.1 Immunovant Inc Company Information &nbsp;13.11.2 Immunovant Inc Graves Disease Treatment Product Portfolios and Specifications &nbsp;13.11.3 Immunovant Inc Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.11.4 Immunovant Inc Main Business Overview &nbsp;13.11.5 Immunovant Inc Latest Developments 14 Research Findings and Conclusion

Report	Global Graves Disease Treatment Market Growth 2025-2031
Selected License	Multi ID: LPI13912

Buyer Information

Order Summary